A conserved rod domain phosphotyrosine that is targeted by the phosphatase PTP1B promotes keratin 8 protein insolubility and filament organization

Journal of Biological Chemistry

Volumn 288, Issue 43, 2013, Pages 31329-31337

  Snider, Natasha T ^a   Park, Haewon ^a   Bishr Omary, M ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEINS; INTERMEDIATE FILAMENTS; PHARMACOLOGICAL INHIBITION; POST-TRANSLATIONAL MODIFICATIONS; PROTEIN PHOSPHORYLATION; PROTEIN-TYROSINE PHOSPHATASE; SOLUBILITY PROPERTIES; TYROSINE PHOSPHORYLATION;

AMINO ACIDS; KERATIN; PHOSPHATASES; SOLUBILITY;

PHOSPHORYLATION;

CYTOKERATIN 8; GLIAL FIBRILLARY ACIDIC PROTEIN; PROTEIN TYROSINE PHOSPHATASE 1B; TYROSINE;

ALEXANDER DISEASE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; INTERMEDIATE FILAMENT; MOUSE; NONHUMAN; PARALOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INSOLUBILITY; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN TARGETING; PROTEOMICS; SITE DIRECTED MUTAGENESIS; SOLUBILITY; SURFACE CHARGE;

ALEXANDER DISEASE; CYTOSKELETON; GFAP; INTERMEDIATE FILAMENTS; KERATIN; PHOSPHOTYROSINE; POST-TRANSLATIONAL MODIFICATION; PROTEIN-TYROSINE PHOSPHATASE (TYROSINE PHOSPHATASE); TYROSINE PHOSPHATASE;

ALEXANDER DISEASE; AMINO ACID MOTIFS; AMINO ACID SUBSTITUTION; ANIMALS; CRICETINAE; HEP G2 CELLS; HUMANS; KERATIN-8; MICE; MUTATION, MISSENSE; NERVE TISSUE PROTEINS; NIH 3T3 CELLS; PHOSPHOTYROSINE; PROTEIN STRUCTURE, TERTIARY; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1; SOLUBILITY;

EID: 84886647368     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.502724     Document Type: Article

References (51)

1. Herrmann, H., Strelkov, S. V., Burkhard, P., and Aebi, U. (2009) Intermediate filaments: primary determinants of cell architecture and plasticity. J. Clin. Invest. 119, 1772-1783
2. Eriksson, J. E., Dechat, T., Grin, B., Helfand, B., Mendez, M., Pallari, H. M., and Goldman, R. D. (2009) Introducing intermediate filaments: from discovery to disease. J. Clin. Invest. 119, 1763-1771
3. Omary, M. B. (2009) "IF-pathies": a broad spectrum of intermediate filament-associated diseases. J. Clin. Invest. 119, 1756-1762
4. Pan, X., Hobbs, R. P., and Coulombe, P. A. (2013) The expanding significance of keratin intermediate filaments in normal and diseased epithelia. Curr. Opin. Cell Biol. 25, 47-56
5. Toivola, D. M., Strnad, P., Habtezion, A., and Omary, M. B. (2010) Intermediate filaments take the heat as stress proteins. Trends Cell Biol. 20, 79-91
6. Ku, N. O., Strnad, P., Zhong, B. H., Tao, G. Z., and Omary, M. B. (2007) keratins let liver live: Mutations predispose to liver disease and crosslinking generates Mallory-Denk bodies.. Hepatology 46, 1639-1649
7. Toivola, D. M., Tao, G. Z., Habtezion, A., Liao, J., and Omary, M. B. (2005) Cellular integrity plus: organelle-related and protein-targeting functions of intermediate filaments.. Trends Cell Biol. 15, 608-617
8. Omary, M. B., Ku, N. O., Strnad, P., and Hanada, S. (2009) Toward unraveling the complexity of simple epithelial keratins in human disease. J. Clin. Invest. 119, 1794-1805
9. Omary, M. B., Ku, N. O., Tao, G. Z., Toivola, D. M., and Liao, J. (2006) "Heads and tails" of intermediate filament phosphorylation: multiple sites and functional insights.. Trends Biochem. Sci. 31, 383-394
10. Snider, N. T., Weerasinghe, S. V., Iñiguez-Lluhí, J. A., Herrmann, H., and Omary, M. B. (2011) keratin hypersumoylation alters filament dynamics and is a marker for human liver disease and keratin mutation.. J. Biol. Chem. 286, 2273-2284
11. Snider, N. T., Leonard, J. M., Kwan, R., Griggs, N. W., Rui, L., and Omary, M. B. (2013) Glucose and SIRT2 reciprocally mediate the regulation of keratin 8 by lysine acetylation. J. Cell Biol. 200, 241-247
12. Kwan, R., Hanada, S., Harada, M., Strnad, P., Li, D. H., and Omary, M. B. (2012) keratin 8 phosphorylation regulates its transamidation and hepatocyte Mallory-Denk body formation. FASEB J. 26, 2318-2326
13. Ku, N. O., Toivola, D. M., Strnad, P., and Omary, M. B. (2010) Cytoskeletal keratin glycosylation protects epithelial tissue from injury. Nat. Cell Biol. 12, 876-885
14. Toivola, D. M., Zhou, Q., English, L. S., and Omary, M. B. (2002) Type II keratins are phosphorylated on a unique motif during stress and mitosis in tissues and cultured cells.. Mol. Biol. Cell 13, 1857-1870
15. Liao, J., Ku, N. O., and Omary, M. B. (1997) Stress, apoptosis, and mitosis induce phosphorylation of human keratin 8 at Ser-73 in tissues and cultured cells. J. Biol. Chem. 272, 17565-17573
16. Ridge, K. M., Linz, L., Flitney, F. W., Kuczmarski, E. R., Chou, Y. H, Omary, M. B., Sznajder, J. I., and Goldman, R. D. (2005) keratin 8 phosphorylation by protein kinase C S regulates shear stress-mediated disassembly of keratin intermediate filaments in alveolar epithelial cells. J. Biol. Chem. 280, 30400-30405
17. Ku, N. O., and Omary, M. B. (2006) A disease- and phosphorylationrelated nonmechanical function for keratin 8. J. Cell Biol. 174, 115-125
18. Sihag, R. K., Inagaki, M., Yamaguchi, T., Shea, T. B., and Pant, H. C. (2007) Role of phosphorylation on the structural dynamics and function of types III and IV intermediate filaments.. Exp. Cell Res. 313, 2098-2109
19. Ivaska, J., Pallari, H. M., Nevo, J., and Eriksson, J. E. (2007) Novel functions of vimentin in cell adhesion, migration, and signaling. Exp. Cell Res. 313, 2050-2062
20. Pan, X., Kane, L. A., Van Eyk, J. E., and Coulombe, P. A. (2011) Type I keratin 17 protein is phosphorylated on serine 44 by p90 ribosomal protein S6 kinase 1 (RSk1) in a growth- and stress-dependent fashion.. J. Biol. Chem. 286, 42403-42413
21. Feng, L., Zhou, X., Liao, J., and Omary, M. B. (1999) Pervanadate-mediated tyrosine phosphorylation of keratins 8 and 19 via a p38 mitogen-activated protein kinase-dependent pathway.. J. Cell Sci. 112, 2081-2090
22. Zhou, Q., Snider, N. T., Liao, J., Li, D. H., Hong, A., Ku, N. O., Cartwright, C. A., and Omary, M. B. (2010) Characterization of in vivo keratin 19 phosphorylation on tyrosine-391. PLoS One 5, e13538
23. Valgeirsdóttir, S., Claesson-Welsh, L., Bongcam-Rudloff, E., Hellman, U., Westermark, B., and Heldin, C. H. (1998) PDGF induces reorganization of vimentin filaments. J. Cell Sci. 111, 1973-1980
24. Angelastro, J. M., Ho, C. L., Frappier, T., Liem, R. K., and Greene, L. A. (1998) Peripherin is tyrosine-phosphorylated at its carboxyl-terminal tyrosine. J. Neurochem. 70, 540-549
25. Ding, S. J., Qian, W. J., and Smith, R. D. (2007) Quantitative proteomic approaches for studying phosphotyrosine signaling. Expert Rev. Proteomics 4, 13-23
26. Hunter, T. (2009) Tyrosine phosphorylation: thirty years and counting. Curr. Opin. Cell Biol. 21, 140-146
27. Artemenko, K. A., Bergström Lind, S., Elfineh, L., Mayrhofer, C., Zubarev, R. A., Bergquist, J., and Pettersson, U. (2011) Optimization of immunoaffinity enrichment and detection: toward a comprehensive characterization of the phosphotyrosine proteome of k562 cells by liquid chromatography-mass spectrometry.. Analyst 136, 1971-1978
28. Gu, T. L., Deng, X., Huang, F., Tucker, M., Crosby, K., Rimkunas, V., Wang, Y., Deng, G., Zhu, L., Tan, Z., Hu, Y., Wu, C., Nardone, J., MacNeill, J., Ren, J., Reeves, C., Innocenti, G., Norris, B., Yuan, J., Yu, J., Haack, H., Shen, B., Peng, C., Li, H., Zhou, X., Liu, X., Rush, J., and Comb, M. J. (2011) Survey of tyrosine kinase signaling reveals ROS kinase fusions in human cholangiocarcinoma. PLoS One 6, e15640
29. Guo, A., Villén, J., Kornhauser, J., Lee, K. A., Stokes, M. P., Rikova, K., Possemato, A., Nardone, J., Innocenti, G., Wetzel, R., Wang, Y., MacNeill, J., Mitchell, J., Gygi, S. P., Rush, J., Polakiewicz, R. D., and Comb, M. J. (2008) Signaling networks assembled byoncogenic EGFR and c-Met. Proc. Natl. Acad. Sci. U. S. A. 105, 692-697
30. Moritz, A., Li, Y., Guo, A., Villén, J., Wang, Y., MacNeill, J., Kornhauser, J., Sprott, K., Zhou, J., Possemato, A., Ren, J. M., Hornbeck, P., Cantley, L. C., Gygi, S. P., Rush, J., and Comb, M. J. (2010) Akt-RSk-S6 kinase signaling networks activated by oncogenic receptor tyrosine kinases. Sci. Signal. 3, ra64
31. Rikova, K., Guo, A., Zeng, Q., Possemato, A., Yu, J., Haack, H., Nardone, J., Lee, K., Reeves, C., Li, Y., Hu, Y., Tan, Z., Stokes, M., Sullivan, L., Mitchell, J., Wetzel, R., Macneill, J., Ren, J. M., Yuan, J., Bakalarski, C. E., Villen, J., Kornhauser, J. M., Smith, B., Li, D., Zhou, X., Gygi, S. P., Gu, T. L., Polakiewicz, R. D., Rush, J., and Comb, M. J. (2007) Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell 131, 1190-1203
32. Bergström Lind, S., Artemenko, K. A., Elfineh, L., Mayrhofer, C., Zubarev, R. A., Bergquist, J., and Pettersson, U. (2011) Toward a comprehensive characterization of the phosphotyrosine proteome. Cell. Signal. 23, 1387-1395
33. Gorospe, J. R., Naidu, S., Johnson, A. B., Puri, V., Raymond, G. V., Jenkins, S. D., Pedersen, R. C., Lewis, D., Knowles, P., Fernandez, R., De Vivo, D., Van Der Knaap, M. S., Messing, A., Brenner, M., and Hoffman, E. P. (2002) Molecular findings in symptomatic and pre-symptomatic Alexander disease patients. Neurology 58, 1494-1500
34. Liem, R. K., and Messing, A. (2009) Dysfunctions of neuronal and glial intermediate filaments in disease. J. Clin. Invest. 119, 1814-1824
35. Quinlan, R. A., Brenner, M., Goldman, J. E., and Messing, A. (2007) GFAP and its role in Alexander disease. Exp. Cell Res. 313, 2077-2087
36. Flint, A. J., Tiganis, T., Barford, D., and Tonks, N. K. (1997) Development of "substrate-trapping" mutants to identify physiological substrates of protein tyrosine phosphatases. Proc.. Natl. Acad. Sci. U. S. A. 94, 1680-1685
37. Felkl, M., Tomas, K., Smid, M., Mattes, J., Windoffer, R., and Leube, R. E. (2012) Monitoring the cytoskeletal EGF response in live gastric carcinoma cells. PLoS One 7, e45280
38. Chung, B. M., Murray, C. I., Van Eyk, J. E., and Coulombe, P. A. (2012) Identification of novel interaction between annexin A2 and keratin 17: evidence for reciprocal regulation.. J. Biol. Chem. 287, 7573-7581
39. Charest, A., Wilker, E. W., McLaughlin, M. E., Lane, K., Gowda, R., Coven, S., McMahon, K., Kovach, S., Feng, Y., Yaffe, M. B., Jacks, T., and Housman, D. (2006) ROS fusion tyrosine kinase activates a SH2 domain-containing phosphatase-2/phosphatidylinositol 3-kinase/mammalian target of rapamycin signaling axis to form glioblastoma in mice.. Cancer Res. 66, 7473-7481
40. Li, B., Antonyak, M. A., Druso, J. E., Cheng, L., Nikitin, A. Y., and Cerione, R. A. (2010) EGF potentiated oncogenesis requires a tissue transglutaminase-dependent signaling pathway leading to Src activation.. Proc. Natl. Acad. Sci. U. S. A. 107, 1408-1413
41. Rotty, J. D., and Coulombe, P. A. (2012) A wound-induced keratin inhibits Src activity during keratinocyte migration and tissue repair. J. Cell Biol. 197, 381-389
42. Majumder, A., Kirabo, A., Karrupiah, K., Tsuda, S., Caldwell-Busby, J., Cardounel, A. J., Keseru, G. M., and Sayeski, P. P. (2011) Cell death induced by the Jak2 inhibitor, G6, correlates with cleavage of vimentin filaments. Biochemistry 50, 7774-7786
43. Utermark, T., Schubert, S. J., and Hanemann, C. O. (2005) Rearrangements ofthe intermediate filament GFAP inprimary human schwannoma cells. Neurobiol. Dis. 19, 1-9
44. Hsiao, V. C, Tian, R., Long, H., Der Perng, M., Brenner, M., Quinlan, R. A., and Goldman, J. E. (2005) Alexander-disease mutation of GFAP causes filament disorganization and decreased solubility of GFAP. J. CellSci. 118, 2057-2065
45. Stuible, M., and Tremblay, M. L. (2010) In control at the ER: PTP1B and the down-regulation of RTks by dephosphorylation and endocytosis. Trends Cell Biol. 20, 672-679
46. Yip, S. C., Saha, S., and Chernoff, J. (2010) PTP1B: a double agent in metabolism and oncogenesis. Trends Biochem. Sci. 35, 442-449
47. Elchebly, M., Payette, P., Michaliszyn, E., Cromlish, W., Collins, S., Loy, A. L., Normandin, D., Cheng, A., Himms-Hagen, J., Chan, C. C., Ramachandran, C, Gresser, M. J., Tremblay, M. L., and Kennedy, B. P. (1999) Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene.. Science 283, 1544-1548
48. Julien, S. G., Dubé, N., Read, M., Penney, J., Paquet, M., Han, Y., Kennedy, B. P., Muller, W. J., and Tremblay, M. L. (2007) Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis.. Nat. Genet. 39, 338-346
49. 446. J. Biol. Chem. 283, 15740-15746
50. Ferrari, E., Tinti, M., Costa, S., Corallino, S., Nardozza, A. P., Chatraryamontri, A., Ceol, A., Cesareni, G., and Castagnoli, L. (2011) Identification of new substrates of the protein-tyrosine phosphatase PTP1B by Bayesian integration of proteome evidence. J. Biol. Chem. 286, 4173-4185
51. -/- mice.. J. Biol. Chem. 280, 15038-15046